Keyphrases
C-reactive Protein
100%
Cancer Diagnosis
50%
Cancer Diagnostics
25%
Cancer Inpatients
100%
Comorbidity
25%
Concurrent Cancer
100%
Copenhagen
25%
Denmark
25%
Diagnostic Ability
25%
Diagnostic Programs
25%
Ficolin
50%
Ficolin-2
25%
Ficolin-3
25%
Final Diagnosis
25%
High Burden
25%
Immunological Biomarkers
25%
Incident Cancer
100%
Infectious Diseases
25%
Inflammation-associated Cancer
100%
Inflammatory Biomarkers
100%
Logistic Regression Analysis
25%
Mannose-binding Lectin
25%
Newly Diagnosed Cancer
25%
Non-associated
25%
Non-specific Symptoms
100%
Outpatient Clinic
50%
Patients Included
25%
Patients with Cancer
25%
Pattern Recognition Receptors
50%
Pentraxin 3 (PTX3)
50%
Plasma Concentration
25%
Self-reported Weight
25%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
University Hospital
25%
Weight Loss
50%
Medicine and Dentistry
Biological Marker
100%
C Reactive Protein
100%
Cancer Diagnosis
11%
Cancer Diagnostics
5%
Comorbidity
5%
Diagnosis
17%
Ficolin
23%
Final Diagnosis
5%
Infectious Disease
5%
Logistic Regression Analysis
5%
Malignant Neoplasm
100%
Mannose Binding Lectin
5%
Multivariate Logistic Regression Analysis
5%
Outpatient
11%
Pattern Recognition Receptor
11%
Pentraxin 3
11%
Physical Disease by Body Function
100%
Physical Examination
5%
Urokinase Receptor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
C Reactive Protein
100%
Comorbidity
4%
Diseases
4%
Ficolin
19%
Malignant Neoplasm
100%
Mannose Binding Lectin
4%
Pattern Recognition Receptor
9%
Pentraxin 3
9%
Physical Disease by Body Function
100%
Urokinase Receptor
100%
Immunology and Microbiology
Blood Level
25%
C-Reactive Protein
100%
Comorbidity
25%
Ficolin
100%
Mannose Binding Lectin
25%
Pattern Recognition Receptor
50%
Urokinase Receptor
100%